Phase 1 Lymphocytic Leukemia, Chronic Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

Acute Lymphoblastic LeukemiaSmall Lymphocytic LymphomaLymphoblastic Lymphoma+4 more

National Cancer Institute (NCI)132 enrolled1 locationNCT06364423

Recruiting

Phase 1

CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia

SLLLymphocytic Leukemia, Chronic

Catapult Therapeutics18 enrolled4 locationsNCT04704323